TranS1 Reports 32% Fall in 3Q Revenues

TranS1 has reported third-quarter revenues of $3.2 million, a 32 percent decreased compared to the same period last year.

Advertisement

The spine device company also saw declines in domestic revenues and gross margin and an increase in net losses.

More Articles on Orthopedic Devices:

DePuy Launches New Trumatch Pin for Orthopedic Implants

Investors Increase Stake in Smith & Nephew

Titan Spine Appoints Marcus Klarl Vice President of Sales

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • SurGenTec’s ION-C earned FDA 510(k) clearance for ION-C navigation instruments with the ION-C posterior cervical facet fixation implant, according to…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.